Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:
in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:
‘1,2-dichloropropane; propylene dichloride | 602-020-00-0 | 201-152-2 | 78-87-5 |
e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).] | 014-046-00-4 | — | —’ |
in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:
‘3,7-dimethylocta-2,6-dienenitrile | 608-067-00-3 | 225-918-0 | 5146-66-7’ |
in Appendix 5,
the following entries are inserted in the table in order of the index numbers set out therein:
‘brodifacoum (ISO);
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin
607-172-00-1 | 259-980-5 | 56073-10-0 |
lead powder;
[particle diameter < 1 mm]
082-013-00-1 | 231-100-4 | 7439-92-1 |
lead massive:
[particle diameter ≥ 1 mm]
082-014-00-7 | 231-100-4 | 7439-92-1’ |
the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:
‘warfarin (ISO);
4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1]
(S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3]
607-056-00-0 |
201-377-6 [1]
226-907-3 [2]
226-908-9 [3]
81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3]’
in Appendix 6,
the following entries are inserted in the table in order of the index numbers set out therein:
‘tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol | 603-061-00-7 | 202-625-6 | 97-99-4 |
gallium arsenide | 031-001-00-4 | 215-114-8 | 1303-00-0 |
Tributyltin compounds, with the exception of those specified elsewhere in this Annex | 050-008-00-3 | — | — |
1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear | 607-710-00-5 | 271-093-5 | 68515-50-4 |
imidazole | 613-319-00-0 | 206-019-2 | 288-32-4 |
bisphenol A; 4,4′-isopropylidenediphenol | 604-030-00-0 | 201-245-8 | 80-05-7 |
phenol, dodecyl-, branched; [1]
phenol, 2-dodecyl-, branched; [2]
phenol, 3-dodecyl-, branched; [3]
phenol, 4-dodecyl-, branched; [4]
phenol, (tetrapropenyl) derivatives [5]
604-092-00-9 |
310-154-3 [1]
[2]
[3]
[4]
[5]
121158-58-5 [1]
[2]
[3]
210555-94-5 [4]
74499-35-7 [5]
chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione | 606-014-00-9 | 223-003-0 | 3691-35-8 |
coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin | 607-059-00-7 | 227-424-0 | 5836-29-3 |
difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin | 607-157-00-X | 259-978-4 | 56073-07-5 |
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin | 607-375-00-5 | 421-960-0 | 90035-08-8 |
disodium octaborate anhydrous; [1]
disodium octaborate tetrahydrate [2]
005-020-00-3 |
234-541-0 [1]
234-541-0 [2]
12008-41-2 [1]
12280-03-4 [2]
bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one | 607-716-00-8 | 249-205-9 | 28772-56-7 |
difethialone (ISO);
3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one
607-717-00-3 | — | 104653-34-1 |
perfluorononan-1-oic acid [1]
and its sodium [2]
and ammonium [3] salts
607-718-00-9 |
206-801-3 [1]
[2]
[3]
375-95-1 [1]
21049-39-8 [2]
4149-60-4 [3]
dicyclohexyl phthalate | 607-719-00-4 | 201-545-9 | 84-61-7 |
triflumizole (ISO);
(1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine
612-289-00-6 | — | 68694-11-1’ |
the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:
‘flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione | 613-166-00-X | — | 103361-09-7’ |